APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted Protein Degradation Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Targeted Protein Degradation Platform Market Outlook and Growth Opportunities 2026

2 May 2026189 pages

Choose your research edition.

Industry ResearchTargeted Protein Degradation Platform Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted Protein Degradation Platform Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Targeted Protein Degradation Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted Protein Degradation Platform Market Outlook and Growth Opportunities 2026189 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted Protein Degradation Platform Market Analysis and Forecast 2026-2032252 pages · $4,950 USD

Market perspective

The global Targeted Protein Degradation Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Targeted Protein Degradation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Targeted Protein Degradation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Targeted Protein Degradation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Targeted Protein Degradation Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Targeted Protein Degradation Platform market include Arvinas, Kymera Therapeutics, Plexium, Nurix, Amphista, Cullgen, Hengrui Pharmaceuticals, Hinova Pharmaceuticals and Ranok Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Targeted Protein Degradation Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Targeted Protein Degradation Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Targeted Protein Degradation Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Targeted Protein Degradation Platform market.

Targeted Protein Degradation Platform Segment by Company

Arvinas

Kymera Therapeutics

Plexium

Nurix

Amphista

Cullgen

Hengrui Pharmaceuticals

Hinova Pharmaceuticals

Ranok Therapeutics

Targeted Protein Degradation Platform Segment by Type

PROTAC Platform

Dual-platform (Molecular Glue and PROTAC)

Targeted Protein Degradation Platform Segment by Application

Cancer

Autoimmune Diseases

Other

Targeted Protein Degradation Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Targeted Protein Degradation Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Targeted Protein Degradation Platform key companies, revenue, market share, and recent developments.

3. To split the Targeted Protein Degradation Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Targeted Protein Degradation Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Targeted Protein Degradation Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Targeted Protein Degradation Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted Protein Degradation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted Protein Degradation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted Protein Degradation Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Targeted Protein Degradation Platform industry.

Chapter 3: Detailed analysis of Targeted Protein Degradation Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Targeted Protein Degradation Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Targeted Protein Degradation Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Targeted Protein Degradation Platform Industry Trends Table 2. Targeted Protein Degradation Platform Industry Drivers Table 3. Targeted Protein Degradation Platform Industry Opportunities and Challenges Table 4. Targeted Protein Degradation Platform Industry Restraints Table 5. Global Targeted Protein Degradation Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Targeted Protein Degradation Platform Revenue Share by Company (2021-2026) Table 7. Global Targeted Protein Degradation Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Targeted Protein Degradation Platform Key Company Manufacturing Base & Headquarters Table 9. Global Targeted Protein Degradation Platform Company, Product Type & Application Table 10. Global Targeted Protein Degradation Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Targeted Protein Degradation Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of PROTAC Platform Table 15. Significant Companies of Dual-platform (Molecular Glue and PROTAC) Table 16. Global Targeted Protein Degradation Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Targeted Protein Degradation Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Targeted Protein Degradation Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Targeted Protein Degradation Platform Sales Value Share by Type (2021-2026) Table 20. Global Targeted Protein Degradation Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cancer Table 22. Significant Companies of Autoimmune Diseases Table 23. Significant Companies of Other Table 24. Global Targeted Protein Degradation Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Targeted Protein Degradation Platform Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Targeted Protein Degradation Platform Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Targeted Protein Degradation Platform Sales Value Share by Application (2021-2026) Table 28. Global Targeted Protein Degradation Platform Sales Value Share by Application (2027-2032) Table 29. Global Targeted Protein Degradation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Targeted Protein Degradation Platform Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Targeted Protein Degradation Platform Sales Value Share by Region (2021-2026) Table 32. Global Targeted Protein Degradation Platform Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Targeted Protein Degradation Platform Sales Value Share by Region (2027-2032) Table 34. Global Targeted Protein Degradation Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Targeted Protein Degradation Platform Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Targeted Protein Degradation Platform Sales Value Market Share by Country (2021-2026) Table 37. Global Targeted Protein Degradation Platform Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Targeted Protein Degradation Platform Sales Value Market Share by Country (2027-2032) Table 39. Arvinas Company Information Table 40. Arvinas Business Overview Table 41. Arvinas Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Arvinas Targeted Protein Degradation Platform Product Portfolio Table 43. Arvinas Recent Development Table 44. Kymera Therapeutics Company Information Table 45. Kymera Therapeutics Business Overview Table 46. Kymera Therapeutics Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Kymera Therapeutics Targeted Protein Degradation Platform Product Portfolio Table 48. Kymera Therapeutics Recent Development Table 49. Plexium Company Information Table 50. Plexium Business Overview Table 51. Plexium Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Plexium Targeted Protein Degradation Platform Product Portfolio Table 53. Plexium Recent Development Table 54. Nurix Company Information Table 55. Nurix Business Overview Table 56. Nurix Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Nurix Targeted Protein Degradation Platform Product Portfolio Table 58. Nurix Recent Development Table 59. Amphista Company Information Table 60. Amphista Business Overview Table 61. Amphista Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Amphista Targeted Protein Degradation Platform Product Portfolio Table 63. Amphista Recent Development Table 64. Cullgen Company Information Table 65. Cullgen Business Overview Table 66. Cullgen Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cullgen Targeted Protein Degradation Platform Product Portfolio Table 68. Cullgen Recent Development Table 69. Hengrui Pharmaceuticals Company Information Table 70. Hengrui Pharmaceuticals Business Overview Table 71. Hengrui Pharmaceuticals Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hengrui Pharmaceuticals Targeted Protein Degradation Platform Product Portfolio Table 73. Hengrui Pharmaceuticals Recent Development Table 74. Hinova Pharmaceuticals Company Information Table 75. Hinova Pharmaceuticals Business Overview Table 76. Hinova Pharmaceuticals Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Hinova Pharmaceuticals Targeted Protein Degradation Platform Product Portfolio Table 78. Hinova Pharmaceuticals Recent Development Table 79. Ranok Therapeutics Company Information Table 80. Ranok Therapeutics Business Overview Table 81. Ranok Therapeutics Targeted Protein Degradation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ranok Therapeutics Targeted Protein Degradation Platform Product Portfolio Table 83. Ranok Therapeutics Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Targeted Protein Degradation Platform Product Image Figure 2. Global Targeted Protein Degradation Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted Protein Degradation Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Targeted Protein Degradation Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. PROTAC Platform Image Figure 8. Dual-platform (Molecular Glue and PROTAC) Image Figure 9. Global Targeted Protein Degradation Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Targeted Protein Degradation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Targeted Protein Degradation Platform Sales Value Share by Type (2021-2032) Figure 12. Cancer Image Figure 13. Autoimmune Diseases Image Figure 14. Other Image Figure 15. Global Targeted Protein Degradation Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Targeted Protein Degradation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Targeted Protein Degradation Platform Sales Value Share by Application (2021-2032) Figure 18. Global Targeted Protein Degradation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Targeted Protein Degradation Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Targeted Protein Degradation Platform Sales Value (2021-2032) & (US$ Million) Figure 21. North America Targeted Protein Degradation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Targeted Protein Degradation Platform Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Targeted Protein Degradation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Targeted Protein Degradation Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Targeted Protein Degradation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Targeted Protein Degradation Platform Sales Value (2021-2032) & (US$ Million) Figure 27. South America Targeted Protein Degradation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Targeted Protein Degradation Platform Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Targeted Protein Degradation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • PROTAC Platform
  • Dual-platform (Molecular Glue and PROTAC)
Applications
  • Cancer
  • Autoimmune Diseases
  • Other
Companies covered
  • Arvinas
  • Kymera Therapeutics
  • Plexium
  • Nurix
  • Amphista
  • Cullgen
  • Hengrui Pharmaceuticals
  • Hinova Pharmaceuticals
  • Ranok Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Targeted Protein Degradation Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Targeted Protein Degradation Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Targeted Protein Degradation Platform Market Dynamics
  1. 2.1 Targeted Protein Degradation Platform Industry Trends
  2. 2.2 Targeted Protein Degradation Platform Industry Drivers
  3. 2.3 Targeted Protein Degradation Platform Industry Opportunities and Challenges
  4. 2.4 Targeted Protein Degradation Platform Industry Restraints
3 Targeted Protein Degradation Platform Market by Company
  1. 3.1 Global Targeted Protein Degradation Platform Company Revenue Ranking in 2025
  2. 3.2 Global Targeted Protein Degradation Platform Revenue by Company (2021-2026)
  3. 3.3 Global Targeted Protein Degradation Platform Company Ranking (2024-2026)
  4. 3.4 Global Targeted Protein Degradation Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Targeted Protein Degradation Platform Company Product Type and Application
  6. 3.6 Global Targeted Protein Degradation Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Targeted Protein Degradation Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Targeted Protein Degradation Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Targeted Protein Degradation Platform Market by Type
  1. 4.1 Targeted Protein Degradation Platform Type Introduction
  2. 4.1.1 PROTAC Platform
  3. 4.1.2 Dual-platform (Molecular Glue and PROTAC)
  4. 4.2 Global Targeted Protein Degradation Platform Sales Value by Type
  5. 4.2.1 Global Targeted Protein Degradation Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Targeted Protein Degradation Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Targeted Protein Degradation Platform Sales Value Share by Type (2021-2032)
5 Targeted Protein Degradation Platform Market by Application
  1. 5.1 Targeted Protein Degradation Platform Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Autoimmune Diseases
  4. 5.1.3 Other
  5. 5.2 Global Targeted Protein Degradation Platform Sales Value by Application
  6. 5.2.1 Global Targeted Protein Degradation Platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Targeted Protein Degradation Platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Targeted Protein Degradation Platform Sales Value Share by Application (2021-2032)
6 Targeted Protein Degradation Platform Regional Value Analysis
  1. 6.1 Global Targeted Protein Degradation Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Targeted Protein Degradation Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Targeted Protein Degradation Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Targeted Protein Degradation Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Targeted Protein Degradation Platform Sales Value (2021-2032)
  7. 6.3.2 North America Targeted Protein Degradation Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Targeted Protein Degradation Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Targeted Protein Degradation Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Targeted Protein Degradation Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Targeted Protein Degradation Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Targeted Protein Degradation Platform Sales Value (2021-2032)
  16. 6.6.2 South America Targeted Protein Degradation Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Targeted Protein Degradation Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Targeted Protein Degradation Platform Sales Value Share by Country, 2025 VS 2032
7 Targeted Protein Degradation Platform Country-level Value Analysis
  1. 7.1 Global Targeted Protein Degradation Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Targeted Protein Degradation Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Targeted Protein Degradation Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Targeted Protein Degradation Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Targeted Protein Degradation Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Targeted Protein Degradation Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Targeted Protein Degradation Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Arvinas
  2. 8.1.1 Arvinas Company Information
  3. 8.1.2 Arvinas Business Overview
  4. 8.1.3 Arvinas Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Arvinas Targeted Protein Degradation Platform Product Portfolio
  6. 8.1.5 Arvinas Recent Developments
  7. 8.2 Kymera Therapeutics
  8. 8.2.1 Kymera Therapeutics Company Information
  9. 8.2.2 Kymera Therapeutics Business Overview
  10. 8.2.3 Kymera Therapeutics Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kymera Therapeutics Targeted Protein Degradation Platform Product Portfolio
  12. 8.2.5 Kymera Therapeutics Recent Developments
  13. 8.3 Plexium
  14. 8.3.1 Plexium Company Information
  15. 8.3.2 Plexium Business Overview
  16. 8.3.3 Plexium Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Plexium Targeted Protein Degradation Platform Product Portfolio
  18. 8.3.5 Plexium Recent Developments
  19. 8.4 Nurix
  20. 8.4.1 Nurix Company Information
  21. 8.4.2 Nurix Business Overview
  22. 8.4.3 Nurix Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nurix Targeted Protein Degradation Platform Product Portfolio
  24. 8.4.5 Nurix Recent Developments
  25. 8.5 Amphista
  26. 8.5.1 Amphista Company Information
  27. 8.5.2 Amphista Business Overview
  28. 8.5.3 Amphista Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amphista Targeted Protein Degradation Platform Product Portfolio
  30. 8.5.5 Amphista Recent Developments
  31. 8.6 Cullgen
  32. 8.6.1 Cullgen Company Information
  33. 8.6.2 Cullgen Business Overview
  34. 8.6.3 Cullgen Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cullgen Targeted Protein Degradation Platform Product Portfolio
  36. 8.6.5 Cullgen Recent Developments
  37. 8.7 Hengrui Pharmaceuticals
  38. 8.7.1 Hengrui Pharmaceuticals Company Information
  39. 8.7.2 Hengrui Pharmaceuticals Business Overview
  40. 8.7.3 Hengrui Pharmaceuticals Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hengrui Pharmaceuticals Targeted Protein Degradation Platform Product Portfolio
  42. 8.7.5 Hengrui Pharmaceuticals Recent Developments
  43. 8.8 Hinova Pharmaceuticals
  44. 8.8.1 Hinova Pharmaceuticals Company Information
  45. 8.8.2 Hinova Pharmaceuticals Business Overview
  46. 8.8.3 Hinova Pharmaceuticals Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hinova Pharmaceuticals Targeted Protein Degradation Platform Product Portfolio
  48. 8.8.5 Hinova Pharmaceuticals Recent Developments
  49. 8.9 Ranok Therapeutics
  50. 8.9.1 Ranok Therapeutics Company Information
  51. 8.9.2 Ranok Therapeutics Business Overview
  52. 8.9.3 Ranok Therapeutics Targeted Protein Degradation Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ranok Therapeutics Targeted Protein Degradation Platform Product Portfolio
  54. 8.9.5 Ranok Therapeutics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst